Skip to content
10-Q

Quarterly Report

BioNeutral Group, Inc

0001213900-14-006810

← back to feed
Filed
Sep 22, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Sep 5, 2014 5.75B sh
Operating Cash Flow Q3 2014 · Jul 31, 2014 −$711.52K
Operating Cash Flow Q3 2014 · Jul 31, 2013 −$606.87K
Short Term Debt Q3 2014 · Jul 31, 2014 $1.21M
Short Term Debt Q3 2014 · Oct 31, 2013 $75K
Cash And Equivalents Q3 2014 · Jul 31, 2014 $16.36K
Cash And Equivalents Q3 2014 · Oct 31, 2013 $702
Cash And Equivalents Q3 2014 · Jul 31, 2013 $7.8K
Cash And Equivalents Q3 2014 · Oct 31, 2012 $676
Stockholders Equity Q3 2014 · Jul 31, 2014 $3.56M
Stockholders Equity Q3 2014 · Oct 31, 2013 $5.38M
Current Liabilities Q3 2014 · Jul 31, 2014 $5.62M
Current Liabilities Q3 2014 · Oct 31, 2013 $2.6M
Total Liabilities Q3 2014 · Jul 31, 2014 $5.57M
Total Liabilities Q3 2014 · Oct 31, 2013 $4.06M
Current Assets Q3 2014 · Jul 31, 2014 $31.93K
Current Assets Q3 2014 · Oct 31, 2013 $25.11K
Total Assets Q3 2014 · Jul 31, 2014 $8.75M
Total Assets Q3 2014 · Oct 31, 2013 $9.28M
Net Income Q3 2014 · Jul 31, 2014 −$1.16M
Net Income Q3 2014 · Jul 31, 2014 −$2.65M
Net Income Q3 2014 · Jul 31, 2013 −$1.01M
Net Income Q3 2014 · Jul 31, 2013 −$2.32M
Operating Income Q3 2014 · Jul 31, 2014 −$967.54K
Operating Income Q3 2014 · Jul 31, 2014 −$2.47M
Operating Income Q3 2014 · Jul 31, 2013 −$827.16K
Operating Income Q3 2014 · Jul 31, 2013 −$2.34M
Gross Profit Q3 2014 · Jul 31, 2014 $5.79K
Gross Profit Q3 2014 · Jul 31, 2014 $16.07K
Gross Profit Q3 2014 · Jul 31, 2013 $2.14K
Gross Profit Q3 2014 · Jul 31, 2013 $3.22K
Cost Of Revenue Q3 2014 · Jul 31, 2014 $3.07K
Cost Of Revenue Q3 2014 · Jul 31, 2014 $14.02K
Cost Of Revenue Q3 2014 · Jul 31, 2013 $1.17K
Cost Of Revenue Q3 2014 · Jul 31, 2013 $1.73K
Revenue Q3 2014 · Jul 31, 2014 $8.86K
Revenue Q3 2014 · Jul 31, 2014 $30.09K
Revenue Q3 2014 · Jul 31, 2013 $3.31K
Revenue Q3 2014 · Jul 31, 2013 $4.95K